Rituximab Formulated Bulk Product Approval Information - Licensing Action

Proper name: Rituximab Formulated Bulk (For Further Manufacturing Use)
Tradename: None
Manufacturer: IDEC Pharmaceutical Corp, San Diego, CA, License #1235
Indication for Use: For use in the manufacture of Rituximab by Genentech, Inc, under a shared manufacturing arrangement
Approval Date: 11/26/97
Type of submission: Biologics license application


Approval Letter - PDF

Reviews (PDF)
    Clinical (Rituximab) (41 pages)
    CMC 1 (4 pages)
    CMC 2 (14 pages)
    Preclinical and Clinical Pharmacology (5 pages)
    Product (6 pages)
    Statistical (9 pages)

Page Last Updated: 05/16/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English